Olio Health, an Indianapolis, IN-based workflow and collaboration platform for the post-acute care and population health industry, announced that it raised $13 million in Series A funding.
The round was led by Fulcrum Equity Partners (“Fulcrum”) with participation from Mutual Capital Partners (“MCP”).
This funding round will be used to further accelerate Olio’s rapid growth through product development and key hires across multiple departments.
Olio's platform provides real-time communication, collaboration, and cost savings to risk-bearing entities and PAC providers and improves the quality of care while decreasing readmission rates and length of stay by making the engagement between health systems, payers, and post-acute providers easy.
Company: Olio Health, Inc.
Round: Series A
Funding Month: Aug 2022
Lead Investors: Fulcrum Equity Partners
Additional Investors: Mutual Capital Partners
Company Website: https://www.olio.health/
Software Category: Workflow and Collaboration platform
About the Company: Founded in 2017, Olia is a workflow and collaboration platform for the post-acute care and population health industry, redefines how population health and utilization teams work with post-acute providers. Olio software increases the volume and scale of engagement between payers, health systems, and physician groups in partnership with the entirety of their post-acute footprint. Olio provides all users with workflow and collaboration tools needed to drive outcomes and operational efficiencies for patients transitioning through various sites of care and simplifies and scales engagement between hospital systems, payers, and post-acute care providers. Olio customers typically see a 36 percent decrease, on average, in readmissions back to the hospital. Olio’s software supports value-based care payers and providers and all levels of post-acute care (SNF, IRF, Home Health, Hospice, LTCH).